Employer profile
Tract Pharmaceuticals
2 certified H-1B filings across 1 fiscal year.
FY2026 filings
2
FY2026 median
$100k
Top role
Bioanalytical Scientist (Lc-Ms)
2 filings
Top state
NC
2 filings
Tract Pharmaceuticals has filed 2 certified H-1B Labor Condition Applications over FY2026. In FY2026, its median certified base salary was $100k ($100k–— interquartile range). The most-filed role is Bioanalytical Scientist (Lc-Ms) (2 filings).
Year-over-year
How Tract Pharmaceuticals hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2026 | 2 | $100k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Bioanalytical Scientist (Lc-Ms) | 2 | $100k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| NC | 2 | $100k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl III
2100%
Frequently asked questions
- Does Tract Pharmaceuticals sponsor H-1B visas?
- Yes. Tract Pharmaceuticals has filed 2 certified H-1B Labor Condition Applications (LCAs) over FY2026. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Tract Pharmaceuticals?
- In FY2026, the median certified H-1B base salary at Tract Pharmaceuticals was $100k, with a 25th–75th percentile range of $100k–—. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Tract Pharmaceuticals hire H-1B workers for?
- Tract Pharmaceuticals's most-filed H-1B role is Bioanalytical Scientist (Lc-Ms) (2 filings). Its top worksite state is NC.
- How many H-1B filings did Tract Pharmaceuticals submit in FY2026?
- Tract Pharmaceuticals had 2 certified H-1B LCA filings in FY2026.